PFDA

If your cholesterol has been drifting upward and your diet and exercise habits do not explain it, an invisible chemical exposure may be part of the story. This test measures a persistent pollutant that lingers in your blood for years and, across many human studies, tracks with higher cholesterol.

This is not something your body makes or needs. It is a manufactured chemical you absorb from food, water, and everyday products, and measuring it tells you how much has quietly accumulated inside you.

What This Chemical Actually Is

PFDA (perfluorodecanoic acid) belongs to a family of thousands of synthetic compounds called PFAS (per- and polyfluoroalkyl substances), often nicknamed forever chemicals because they resist breaking down. Your cells do not produce it and have no use for it. It enters your body from outside sources and then sticks around.

Once inside, it binds tightly to proteins in your blood, mainly albumin, and accumulates in blood and other protein-rich tissues such as the liver. That is why a single blood draw can detect it and why the number reflects your accumulated exposure rather than what you ate yesterday. This test measures the concentration of the chemical in your blood, and that concentration signals your internal body burden built up over months to years.

This is a research-stage measurement. There are no standardized clinical cutoffs that tell you when a level is safe or dangerous, and a single reading should not drive medical decisions on its own. What it does offer is a concrete look at an exposure most people never see, plus a baseline you can track as the science matures.

The Cholesterol Connection

One of the more studied signals for this chemical is in blood fats. Higher blood levels have been linked to higher total cholesterol, LDL cholesterol (the kind that drives artery buildup), and apolipoprotein B (a protein that counts the harmful cholesterol particles) across teenagers, children, and older adults. The strongest and most consistent lipid evidence across the PFAS family is for its close relatives PFOA and PFOS; for PFDA specifically the picture is more mixed, and some pooled analyses have found the association with triglycerides pointing the opposite way. So treat this as a plausible contributor rather than a settled cause.

In a national Canadian survey of about 6,800 people, a modest rise in blood PFDA was associated with 10.7% higher LDL cholesterol, 7.0% higher triglycerides, and 2.8% higher total cholesterol. Among nearly a thousand Norwegian adolescents, those in the highest quarter of blood levels were about 2.36 times as likely to have an unhealthy cholesterol pattern (dyslipidemia) as those in the lowest quarter.

What makes this more than a snapshot is that some of the link holds over time. In a 10-year study of older adults, people whose blood levels rose also tended to see their total cholesterol, triglycerides, and HDL cholesterol rise. A separate study following adults over three decades found a similar upward pull on total and LDL cholesterol.

What this means for you: if you are working to bring cholesterol down and the numbers are stubborn, knowing your exposure level adds context that a standard lipid panel alone cannot. It does not replace your cholesterol tests, but it can point to a background contributor worth addressing at the source.

Liver Enzyme Signals

Alongside cholesterol, higher blood levels have been tied to higher liver enzymes, most consistently GGT (gamma-glutamyl transferase, an enzyme that rises when the liver is stressed). In the same Canadian survey, a modest increase in blood PFDA was associated with 15.5% higher GGT.

This is a biochemical nudge, not a diagnosis of liver disease. It suggests the exposure may be interacting with how your liver handles fats and processing, which fits with the cholesterol findings. Pregnancy cohorts in China have reported similar shifts in liver markers including ALT and AST.

Pregnancy and Birth Outcomes

This chemical crosses the placenta. In matched mother and newborn pairs, it was measurable in cord blood, with roughly a third of the maternal level reaching the baby. That means a pregnant person's exposure is also, in part, the developing baby's exposure.

The outcome data are genuinely mixed. A pooled analysis of studies linked higher levels to miscarriage, with roughly 1.87 times the odds for each 1 ng/mL higher, but a large 2026 study within the Norwegian Mother, Father and Child Cohort (about 2,500 pregnancies) found no clear link between PFAS levels, including PFDA, and miscarriage. One pregnancy cohort tied higher early-pregnancy levels to about 1.6 times the odds of a placenta-related preterm birth, and a separate pooled analysis connected higher levels to small-for-gestational-age babies and modestly lower birth weight.

What this means for you: if you are pregnant or planning to be, this exposure is one of the few environmental inputs you can actually measure and act on before conception. Because these findings come from population studies rather than individual diagnosis, and because they do not all agree, interpret a result with a clinician who can weigh it against your full picture.

Kidney Filtration and Counterintuitive Findings

Not every association points the obvious direction. In older adults and in a 10-year study of young people, higher blood levels lined up with higher eGFR (a measure of how fast the kidneys filter blood). On the surface, faster filtration looks like healthier kidneys, which seems to contradict the idea that this is a harmful exposure.

Here is how both findings fit together. This is not a simple good-number or bad-number marker; it is an exposure indicator, and the same exposure can correlate with different things for different reasons. Researchers read the higher filtration as possible early over-filtration (a strain pattern called hyperfiltration), not as a benefit, and they note that kidney clearance also shapes how much of the chemical stays in blood, so cause and effect are genuinely tangled. Other inverse or hard-to-interpret findings exist too, such as links to lower childhood blood pressure and, in one study, slower disability progression in multiple sclerosis. None of these should be read as the chemical being protective; they reflect the messiness of studying a persistent exposure across very different populations.

Why One Reading Is Not Enough

This chemical behaves differently from a fast-moving lab value like glucose. Related long-chain forever chemicals stay in blood for years (for comparison, two well-studied cousins persist with half-lives of roughly 3.5 and 4.8 years), and PFDA itself is thought to linger for a similar span, with one modeling estimate near 7 years, though that figure carries substantial uncertainty. So your level changes slowly and mostly when your exposure sources change. That stability is an advantage: a trend over time tells you whether your total exposure is climbing, holding, or falling.

A practical rhythm is to establish a baseline now, then retest after you make a meaningful change such as filtering your water or leaving a high-exposure job. Because the level clears so slowly, allow at least a year and often longer for a shift to become clear. After that, a periodic check lets you watch the trajectory. Because population levels have risen and fallen across different eras and places, your own repeated data is far more informative than comparing a single value to a general reference.

What to Do With an Unexpected Result

If your level comes back higher than you expected, the first move is not to panic but to widen the lens. This chemical is almost never present alone, so order a broader PFAS panel to see the full pattern, since these compounds tend to travel together and share sources.

Pair the result with a lipid workup, including LDL cholesterol, apolipoprotein B, and GGT, to see whether the associated metabolic pattern is showing up in your own numbers. Then hunt for the source: test your drinking water, review food packaging habits, and consider occupational exposure. If levels are markedly high, if you have a known contaminated water supply, or if you are pregnant, an environmental health or toxicology specialist can help interpret the result and guide next steps.

When Results Can Be Misleading

A few factors can distort how you read a single value:

• Kidney function: because clearance affects how much of the chemical stays in blood, kidney status can shift the number and should be considered when interpreting a result.
• Sampling era and matrix: levels vary a lot by calendar year and population, and older results measured in serum versus plasma using different lab methods are not always directly comparable, so trends within one consistent method are more reliable than comparing across labs and years.
• Near the detection limit: blood levels of this chemical are often low, and values close to a lab's detection threshold carry more uncertainty, so small differences may not be meaningful.
• Pregnancy physiology: blood volume and other pregnancy-related changes can influence concentrations, which matters when comparing a result during pregnancy to one outside of it.